Tuesday, August 22, 2017 3:15:17 PM
"Senomyx has made important progress during the first half of 2017, highlighted by significant direct sales growth and advancing siratose, our novel natural high intensity sweetener," said Senomyx Chief Executive Officer John Poyhonen. "Given our progress toward key goals, we believe the timing is right to engage Liolios based on their proven track record in assisting companies like ours. As we move forward, we are confident that Liolios will be a valuable resource to assist us on our financial communications and our presence in the investment community."
Liolios will work closely with Senomyx management to develop and deploy a comprehensive capital markets strategy and program. Activities will include delivering effective messaging and corporate positioning, as well as introductions to sell-side analysts, institutional investors and other key influencers. Liolios will also assist in scheduling road shows and procuring invitations to financial conferences for Senomyx management.
For additional information about Senomyx, contact Liolios at 949-574-3860 or email SNMX@liolios.com.
About Liolios Group
Liolios is a comprehensive financial communications firm specializing in publicly traded companies. The firm aims to deliver superior performance in corporate messaging and positioning, capital markets advisory, investor awareness and capital formation. Founded in 1999, Liolios' executives have extensive experience in finance and investments and represent public and private companies in a wide range of industries, including technology, consumer/internet retail, life sciences, natural resources, financial services and business services. For more information about Liolios, visit www.liolios.com.
About Senomyx, Inc.
Senomyx discovers novel flavor ingredients and natural high intensity sweeteners that allow food and beverage companies to create better-for-you products. Under its direct sales program, Senomyx sells its Complimyx® brand flavor ingredients, Sweetmyx®, Savorymyx®, and Bittermyx®, to flavor companies for use in a wide variety of foods and beverages. In addition, Senomyx has partnerships with leading global food, beverage, and ingredient supply companies, which are currently marketing products that contain Senomyx's flavor ingredients. For more information, please visit www.senomyx.com.
Forward-Looking Statements
This press release may contain forward-looking statements relating to the development and implementation of the Company's products and services and future operation results, including statements regarding the Company that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. The words "expects," "anticipates," variations of such words, and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Factors that could affect the Company's actual results include the progress and costs of the development of products and services and the timing of the market acceptance. The subject Companies expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
Investor Relations Contact:
Matt Glover and Najim Mostamand
Liolios Group, Inc.
949-574-3860
SNMX@liolios.com
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM